Can genetic testing added to health checkups predict diseases? Are consumer/DTC genetic tests accurate and worth doing?
Genetic testing often added to health checkups uses DNA variants to estimate disease risk, but for most common diseases, genetics is only one of many influencing factors—'higher risk' does not mean you will definitely get the disease, and 'lower risk' does not rule it out. Consumer (DTC) genetic tests are mostly probabilistic, not diagnostic, and often test only partial variants, potentially missing important mutations. Clinically valuable genetic tests (e.g., hereditary cancer testing for those with family history) are arranged by physicians with genetic counseling, differing from 'panel' screening for healthy individuals. The following is a neutral summary of what it can and cannot do, for informational purposes only, not medical advice.
What do consumer genetic tests measure?
Consumer (DTC) or self-paid genetic tests analyze DNA variants to estimate disease risk, ancestry, carrier status, or drug response (pharmacogenetics):
- Formats range from 'single gene' to SNP chip 'risk' reports, to recent 'polygenic risk scores (PRS)'
- Often marketed as add-ons to premium health check-ups
- Key point: Most results are probabilistic risk estimates, not disease diagnoses
Can they predict disease? 'Risk' does not equal 'fate'
For most common, complex diseases, genetics is only one of many factors (along with lifestyle and environment):
- 'Higher risk' does not mean you will definitely get the disease; 'lower risk' or negative result does not rule it out
- Most results are probabilistic risk estimates and cannot be used alone for medical decisions
- The US CDC, NIH, etc., emphasize that such risk reports are not diagnostic tools
Limitations of consumer genetic testing
Consumer genetic tests have several important limitations; results should not be overinterpreted:
- Only test a subset of variants: may miss most clinically significant mutations (e.g., some DTC BRCA reports test only a few specific variants, missing most BRCA mutations)
- False positives/false negatives exist; third-party reinterpretation of raw data is error-prone
- The US FDA warns: Before taking any medical action, DTC results should be confirmed by clinical-grade testing
- Polygenic risk scores (PRS) are still in research/early stages, with limited individual clinical utility and reduced accuracy across populations (mostly derived from European data)
Which genetic tests have clinical value?
Genetic testing is not useless—but 'clinically valuable' tests differ from 'panel-based screening':
- Valuable scenarios: diagnosis of suspected genetic diseases, hereditary cancer testing for individuals with significant personal or family history (e.g., BRCA, Lynch syndrome), carrier screening, and pharmacogenetic testing in specific contexts
- These are arranged by physicians based on personal/family history and paired with 'genetic counseling,' different from add-on panels for healthy individuals.
- International guidelines (e.g., US USPSTF) do not recommend routine BRCA testing for the general population without family history risk.
Should you add it? Privacy and neutral perspectives
For asymptomatic individuals without special family history, the evidence for panel-type DTC disease risk genetic testing is limited:
- May bring 'false reassurance' or unnecessary anxiety and follow-up tests.
- When clinically indicated (family history, symptoms), it should be done through physicians and genetic counseling; results are probabilistic, and lifestyle still matters.
- Privacy: Genetic data is highly sensitive personal information. Taiwan currently has no specific 'genetic non-discrimination' law; be aware of concerns regarding insurance/employment data use; discuss with qualified professionals before considering.
FAQ
Can genetic testing added to health checkups accurately predict whether I will get a certain disease?
Most cannot. For common complex diseases, genetics is only one of many factors; 'higher risk' does not mean you will definitely get the disease, and 'lower risk' does not rule it out. Consumer genetic tests are mostly probabilistic risk estimates, not diagnostic tools, and cannot be used alone for medical decisions. If in doubt, consult a physician or genetic counselor.
Are consumer (DTC) genetic tests accurate? What are the limitations?
There are many limitations: they often test only partial variants, potentially missing most clinically significant mutations (e.g., some DTC BRCA reports test only a few specific variants); there are false positives/false negatives; third-party reinterpretation of raw data is prone to errors. The US FDA advises that any medical action should be confirmed by clinical-grade testing.
Are polygenic risk scores (PRS) reliable?
PRS is still in the research/early stage, mainly validated at the population level, with limited value for individual clinical decisions; moreover, they are mostly derived from European population data, reducing accuracy for other ethnic groups. It is 'under research/not routine,' and a score should not be taken as a definitive personal risk.
Is genetic testing completely useless?
No. Clinically valuable scenarios include: diagnosis of suspected genetic diseases, hereditary cancer testing for individuals with significant family history (e.g., BRCA, Lynch syndrome), carrier screening, and specific pharmacogenetic testing. These are arranged by physicians based on personal/family history and accompanied by genetic counseling, unlike add-on panels for healthy individuals.
For the general population without family history, is it worth paying out-of-pocket for genetic testing panels?
For asymptomatic individuals without significant family history, the evidence for the benefit of panel-based disease risk genetic testing is limited, and it may cause false reassurance or unnecessary anxiety and follow-up tests. International guidelines do not recommend routine BRCA testing for the general population. Whether to undergo such testing should be discussed with a physician, not driven by marketing.
Are there privacy or insurance concerns with genetic testing?
Yes. Genetic data is highly sensitive personal information. Taiwan currently lacks specific 'genetic non-discrimination' legislation (unlike the US GINA, which also does not cover life insurance). Concerns about data use in insurance, employment, etc., are still under discussion. Before testing, it is advisable to understand how data will be stored and used, and to discuss with qualified professionals.
This page is a neutral compilation of information for reference only, not Medical advice, and does not constitute any diagnostic commitment.